Dong-kuk K. Ahn
Daegu, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Differential Modulation of Spinal Angiotensin-Converting Enzymes Plays a Critical Role in the Development of Trigeminal Neuropathic Pain.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 16, 2026
BTX-A inhibited trigeminal neuralgia by blocking the NLRP3 pathway in rats.
Journal: Brain research bulletin
Published: February 05, 2025
Can Botulinum Toxin Type E Serve as a Novel Therapeutic Target for Managing Chronic Orofacial Pain?
Journal: Toxins
Published: January 24, 2025
Microiontophoretic Application of Dynorphin in Dental Pain: Excitatory or Inhibitory Effects.
Journal: Journal of pain research
Published: October 02, 2024
Blockade of Piezo2 Pathway Attenuates Inflammatory and Neuropathic Pain in the Orofacial Area.
Journal: Pain research & management
Published: June 13, 2024
Botulinum toxin type A is a potential therapeutic drug for chronic orofacial pain.
Journal: Journal of oral biosciences
Published: April 16, 2024
Structural reorganization of medullary dorsal horn astrocytes in a rat model of neuropathic pain.
Journal: Brain structure & function
Published: April 12, 2024
Differential Regulation of Intracisternally Injected Angiotensin II-Induced Mechanical Allodynia and Thermal Hyperalgesia in Rats.
Journal: Biomedicines
Published: April 27, 2023
Cellular Mechanisms Mediating the Antinociceptive Effect of Botulinum Toxin A in a Rodent Model of Trigeminal Irritation by a Foreign Body.
Journal: The journal of pain
Published: November 10, 2021
Mannitol Enhances the Antinociceptive Effects of Diphenhydramine as an Alternative Local Anesthetic.
Mannitol Enhances the Antinociceptive Effects of Diphenhydramine as an Alternative Local Anesthetic.
Journal: Pain research & management
Published: June 18, 2020
Early Blockade of EphA4 Pathway Reduces Trigeminal Neuropathic Pain.
Journal: Journal of pain research
Published: February 10, 2020
Botulinum toxin type A enhances the inhibitory spontaneous postsynaptic currents on the substantia gelatinosa neurons of the subnucleus caudalis in immature mice.
Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology
Published: February 14, 2018
Last Updated: 09/26/2026